|
CL2025004057A1
(es)
|
|
Intermedio inhibidor de dpp1, y método de preparación para el mismo y uso del mismo en medicamentos.
|
|
CL2025003770A1
(es)
|
|
Método para obtener terapia celular avanzada con células mesenquimales y ácido hialurónico para lesiones óseas.
|
|
BR102023014872A2
(https=)
|
|
|
|
BR102023012440A2
(https=)
|
|
|
|
BR102023010976A2
(https=)
|
|
|
|
BR102023009641A2
(https=)
|
|
|
|
BR102023008688A2
(https=)
|
|
|
|
BR102023007252A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR102023000289A2
(https=)
|
|
|
|
BR102022026909A2
(https=)
|
|
|
|
BR202022001779U2
(https=)
|
|
|
|
BR202022000931U2
(https=)
|
|
|
|
CN307046649S
(https=)
|
|
|
|
BY13166U
(https=)
|
|
|
|
BY13155U
(https=)
|
|
|
|
BY13165U
(https=)
|
|
|
|
CN307047190S
(https=)
|
|
|
|
BY13163U
(https=)
|
|
|
|
BY13162U
(https=)
|
|
|
|
CN307047057S
(https=)
|
|
|
|
BY13161U
(https=)
|
|
|
|
BY13170U
(https=)
|
|
|
|
CN307047591S
(https=)
|
|
|